News
Cephalon Announces FDA Approval of a Risk Evaluation and...
Cephalon, Inc.announced that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) has been approved by the U.S. Food and...
News
Bristol-Myers Squibb Completes Acquisition of ZymoGenetics, Inc.
Bristol-Myers Squibb Company announced that it has completed its previously announced acquisition of ZymoGenetics, Inc.. As a result of the transaction, ZymoGenetics has become a...
News
BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3...
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, announced that its partner Auxilium Pharmaceuticals, Inc. (Auxilium) has dosed the first subject...
News
AstraZeneca and PoZEN received approval for VIMOVO in Europe
AstraZeneca and POZEN Inc. today announced that VIMOVO (naproxen/ esomeprazole magnesium) 500/20 mg modified-release tablets has cleared an important regulatory milestone by receiving positive agreement...
News
Bexion Pharmaceuticals Continues to Gain Support from National Cancer...
Bexion Pharmaceuticals announced that it has been awarded a $1.5M Phase II Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI). The...
News
Abbott Named One of the “Top Employers” in the...
Abbott Park, Illinois was named one of the top 20 employers in Science magazine's 2010 Top Biopharma Employers survey. The annual survey seeks to identify...
News
Lupin Announces Final FDA Approval of Generic Hyzaar® and...
Pharma Major, Lupin Limited announced that its U.S subsidiary, Lupin Pharmaceuticals, Inc. (LPI) has been granted final approval for the company's generic versions of Merck's...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.